SlideShare une entreprise Scribd logo
1  sur  57
MSB 203: CARDIORESPIRATORY SYSTEM




                                           Dr. G.K. Maiyoh
                         Department of Medical Biochemistry



                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESSYS.2013
March 20, 2013                                                1
Lecture Objective
1.    To study the structure of physiologically important
phospholipid classes- glycerophospholipids and     sphingolipids.

2.     To discuss the synthesis of phospholipids of clinical and
physiological relevance and their degradation by
phospholipases.

3.     To study the role of phospholipids like phosphatidylinositol
       in signal transduction and membrane anchoring choline,
ethanolamine and serine, cardiolipin and sphingomyelin .

                  GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013    YS.2013                                             2
Lecture Outline
1.       Introduction to Lipid

2.           Overview of phospholipids.

3.           Structure of Glycerophospholipids and sphingolipids.

4.           Synthesis of phospholipids: Phosphatidic acid, phosphatidyl-choline,
             ethanolamine and serine, cardiolipin and sphingomyelin etc.

5.           Degradation of phospholipids by phosphalipases.

6.           Role of phosphatidyl choline in lung surfactant

7.     Role of phsophatidylinositol in signal transduction and
membrane anchoring .

                         GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013           YS.2013                                                    3
Lipids defined

•A diverse group of compounds found in all living
cells, insoluble in water but soluble in organic solvents
such as ether, acetone and chloroform
Lipids classification

       - Fatty acids (saturated/unsaturated)
      - Glycerol
      -Triglycerides
      -Phospholipids (glycero/sphingo)
      -Sterols (cholesterol and cholesterol esters)


                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               5
Cholesterol



                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               6
Fatty Acids
    The Length of the Carbon Chain
          long-chain, medium-chain, short-chain
    The Degree of Unsaturation
          saturated, unsaturated, monounsaturated,
             polyunsaturated
    The Location of Double Bonds
          omega-3 fatty acid, omega-6 fatty acid



                     GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013       YS.2013                               7
The Length of the Carbon Chain

                       Short-chain Fatty Acid
                         (less than 6 carbons)

                               Medium-chain Fatty Acid
                               (6-10 carbons)


                                       Long-chain Fatty Acid
                                       (12 or more carbons)
                   GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013     YS.2013                                     8
Phosphatidic acid Biosynthesis
TG and phospholipids share the same initial
 synthesis pathway
TG and phospholipids both contain fatty acids linked
 by ester bonds to a glycerol , and are described as
 glycerolipids .
The synthesis pathway starts by reducing
 dihydroxyacetone phosphateto glycerol
 phosphate, with NADH as the reductant.
                     NAD+ dependent glycerol phosphate dehydrogenase
dihydroxyacetone phosphate + NADH + H+                L-glycerol-3-
  phosphate + NAD+
(Alternatively, existing glycerol molecules may be
 phosphorylated by glycerol kinase.




                     glycerol kinase
   glycerol + ATP                      L-glycerol-3-
   phosphate + ADP
Formation of active CoA thioester
This is followed by two successive additions of acyl
 esters.
Fatty acid (typically 16-18 C atoms) is first
 converted to the active CoA thioester by acyl CoA
 synthetase:
                            acyl CoA synthetase
 stearate (18:0) + HSCoA + ATP                   stearoyl-CoA +
  5'-AMP + PPi
Acylglycerols
Acyl-CoA is then used to donate acyl ester groups to the
   glycerol backbone:
                                                acyltransferase
L-glycerol-3-phosphate + acyl-CoA                               1-acylglycerol-3-
  phosphate + HSCoA


                                            acyltransferase
1-acylglycerol-3-phosphate + stearoyl-CoA                1,2-diacylglycerol-3-phosphate + HSCoA

                                                              Phosphatidic acid
1. glycerol phosphate dehydrogenase
          2. glycerol kinase
          3. acyl transferase
Phosphatidic acid
The last product, 1,2-diacylglycerol-3-phosphate, is
 also known as phosphatidic acid
Its phospholipid derivatives are phosphatidyl-X.

Phospholipids also tend to have a saturated fatty
 acid in position 1 and an unsaturated fatty acid in
 position 2.
The fat synthesis (TG) pathway branches here
 from glycerophospholipid synthesis
TG formation
Phosphate is first removed by phosphatidic acid
 phosphatase,
The acyltransferase can then add the third acyl
 ester group tomake triacylglycerol (or fat)
Phospholipid
     Polar compounds composed of alcohol attached by a
phosphodiester bridge to either diacylglycerol or sphingosine.

     Amphipathic in nature, has a hydrophilic head (phosphate +
      alcohol e.g., serine, ethanolamine, and choline) and a long,
hydrophobic tail (fatty acids or derivatives ).

          In membranes, the hydrophobic portion is associated with the
           nonpolar portions such as glycolipids, proteins, and cholesterol.

          The hydrohilic polar head extends outward, facing intracellular
           or extracellular aqueous environment . See figure on next slide

                        GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
    March 20, 2013      YS.2013                                          16
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               17
Glycero-
 phospholipids


Phosphatidic acid



4 major
glycerophospholipids
are polar/charged:
          Membrane phospholipids also function as :
              a reservoir for intracellular messengers, and,
              for some proteins, phospholipids serve as anchors
             to cell membranes.

          Non-membrane-bound phospholipids serve additional
           functions in the body, for example,
              •1 as components of lung surfactant and
              •2 essential components of bile, where their
              detergent properties aid "in the solubilization of
                 cholesterol.

                      GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
    March 20, 2013    YS.2013                                  19
Glycerophospholipids : are formed from phosphatidic
       acid (PA) and an alcohol.

                 Serine + PA -- phosphatidylserine (PS)

              Ethanolamine + PA -- phosphatidylethanolamine
       (cephalin)

                 Choline + PA -- phosphatidylcholine (lecithin) PC

                 Inositol + PA -- phosphatidylinositol (PI)

                 Glycerol + PA -- phosphatidylglycerol (PG)

                       GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013         YS.2013                                       20
(Cardiolipin)
Two molecules of phosphatidic acid esterified through phosphate
to an additional molecule of glycerol are called cardiolipin. (see
next slide)

This is the only human glycerophospholipid that is antigenic.

cardiolipin is recognized by antibodies raised against Treponema
the bacterium that causes syphylis

[Cardiolipin is an important component of the inner
mitochondrial membrane and bacterial membranes.]



                   GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013     YS.2013                                           21
• Diphosphatidyl glycerol (cardiolipin)


  O                                           O
 RCO-CH2                                  CH2-OCR
  O                                            O
 RCO-CH                                   CH-OCR
              O         OH         O
      CH2-O-P-O-CH2-CH-CH2-O-P-O-CH2
             O-                    O-
                      glycerol
Plasmalogens

      When the fatty acid at carbon 1 of a glycerolphospholipid is
      replaced by an unsaturated alkyl group attached by an
      ether (rather than by an ester) linkage to the core glycerol :
molecule, a plasmalogen is produced.

          Phosphatidalethanolamine is abundant in nerve tissue is a
          plasmalogen.

          Phosphatidalcholine (abundant in heart muscle) is the other
          quantitatively significant ether lipid in mammals.


                       GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
   March 20, 2013      YS.2013                                          23
March 20, 2013                                         24
                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
Sphingophospholipids (or sphingomyelin)
       The backbone of sphingomyelin is the amino alcohol
sphingosine, rather than glycerol.

       A long-chain fatty acid is attached to the amino group of
sphingosine through an amide linkage, producing a ceramide,
which serve as a precursor of glycolipids.

           The alcohol group at carbon 1 of sphingosine is esterified to
          phosphorylcholine, producing sphingomyelin, the only
          significant sphingophospholipid in humans.

          Sphingomyelin is an important component of the myelin of nerve
          fibers (myelin sheath) that insulates and protects neuronal fibers
          of the central nervous system.
                       GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
   March 20, 2013      YS.2013                                             25
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               26
Synthesis of Phospholipid

1. Glycerophospholipid (GP) synthesis involves either
   a. The donation of phosphatidic acid from CDP-diacylglycerol to
      an alcohol, or
   b. The donation of phosphomonoester of the alcohol from CDP-
      alcohol to 1,2-diacylglycerol. CDP is cytidine diphosphate.

2. In both cases, the CDP-bound structure is considered an "activated
   intermediate," and CMP is released as a side product of GP
   synthesis.

3. A key concept in phosphoglyceride synthesis, is activation either of
   diacylglycerol or the alcohol to be added by linkage with CDP.
                    GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
  March 20, 2013    YS.2013                                         27
1




                                                       CMP




      2




                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                                 28
4. The fatty acids esterifies to the glycerol alcohol groups can vary
   widely, contributing to the heterogeneity of this group of compounds.

5. Phospholipids are synthesized in the Smooth ER-- then transported to
   Golgi apparatus and then membranes organelles or plasma
   membrane, or are secreted by exocytosis

6. There are two classes of phospholipids: Those have either glycerol as
   a backbone or contain sphingosine.

7. Both classes are found in membranes and play a role in the
   generation of lipid-signaling molecules.

                    GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
  March 20, 2013    YS.2013                                        29
Synthesis of phosphatidylethanolamine (PE) &
                        phosphatidylcholine (PC)

•          PC & PE are most abundant phospholipids in eukaryotic cells.

•       The primary route of synthesis uses choline and ethanolamine
     obtained either from the diet or turnover of the body's phospholipids.

•          In the liver, PC also can be synthesized from phosphatidylserine
           (PS) and PE.




                        GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
    March 20, 2013      YS.2013                                         30
1. Synthesis of PE and PC from preexisting choline
          and ethanolamine

          These synthetic pathways involve the phosphorylation of
          choline or ethanolamine by kinases, followed by conversion to
          the activated form, CDP-choline or CDP-ethanolamine

        Finally, choline-phosphate or ethanolamine-phosphate is
transferred from the nucleotide (leaving CMP) to a molecule        of
diacylglycerol.

       Significance of choline reutilization The reutilization of
choline is important because, whereas humans can synthesize
choline de novo, the amount made is insufficient for our needs.     Thus,
choline is an essential dietary nutrient with an adequate   intake of 550
mg for men and 420 mg for women.
                       GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
   March 20, 2013      YS.2013                                       31
Role of PC in lung surfactant

1. The major lipid component of lung surfactant--the extracellular fluid
   layer lining the alveoli is dipalmitoyl-phosphatidylcholine (DPPC, or
   dipalmitoylecithin).
   In DPPC, positions 1 and 2 on the glycerol are occupied by palmitate.
2. DPPC, made and secreted by granular pneumocytes
3. Surfactant serves to decrease the surface tension of this fluid layer,
   reducing the pressure needed to reinflate alveoli, thereby preventing
   alveolar collapse (atelectasis).
3. Respiratory distress syndrome (RDS) in pre-term infants is associated
   with insufficient surfactant production, and is a significant cause of
   neonatal deaths .
5. Lung maturity of the fetus can be gauged by determining the ratio of
   DPPC to sphingomyelin, usually written as the L (for lecithin)/S ratio,
   in amniotic fluid.
                     GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
   March 20, 2013    YS.2013                                         32
6. A ratio of 2 or above is evidence of maturity, because it
            reflects the major shift from sphingomyelin to DPPC
            synthesis that occurs in the pneumocytes at about 32
            weeks of gestation.
         7. 1- Lung maturation can be accelerated by giving the
            mother glucocorticoids shortly before delivery. 2-
            Administration of natural or synthetic surfactant (by
            intratracheal instillation is also used in the prevention and
            treatment of infant RDS.
         8. Respiratory distress syndrome due to an insufficient
            amount of surfactant can also occur in adults whose
            surfactant producing pneumocytes have been damaged or
            destroyed, for example, as an adverse side effect of
            immuno-suppressive medication or chemotherapeutic
            drug use.
                      GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013        YS.2013                                           33
2: Synthesis of PC from phosphatidylserine (PS) in
 liver

 1. The liver requires a mechanism for producing PC, even when free
     choline levels are low, because it exports significant amounts of
     PC in the bile and as a component of serum lipoproteins.
 2. To provide the needed PC, PS is decarboxylated to
     phosphatidylethanolamine (PE) by PS decarboxylase, an enzyme
     requiring pyridoxal phosphate as a cofactor.
 3. PE then undergoes 3 methylation steps to produce PC, as
 illustrated in the next slide.
 4. S-adenosylmethionine (SAM) is the methyl group donor lead to
 S-adenosylhomocysteine

                  GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013    YS.2013                                         34
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               35
C. Phosphatidylserine (PS)

      The primary pathway for synthesis of PS in
      mammalian tissues is provided by the base
      exchange reaction, in which the ethanolamine of
      PE is exchanged for free serine

      This reaction, although reversible, is used primarily
      to produce the PS required for membrane synthesis.



                   GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013     YS.2013                                    36
D. Phosphatidylinositol (PI)

 PI is synthesized from free inositol and CDP-diacylglycerol
 PI is an unusual phospholipid in that it often contains
 stearic acid on carbon 1 and arachidonic acid on carbon 2
 of the glycerol.

 PI, therefore, serves as a reservoir of arachidonic acid in
 membranes and, thus, provides the substrate for
 prostaglandin synthesis when required.



                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                                   37
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               38
1. Role of PI in signal transmission across membranes:

a. The phosphorylation of membrane-bound phosphatidylinositol
   produces polyphosphoinositides, for example,
   phosphatidylinositol 4,5- bisphosphate (PIP2). (See next slide)

b. The degradation of PIP2 by phospholipase C occurs in response
   to the binding of neurotransmitters, hormones, and growth factors
   to receptors on the cell membrane.

c. The products of this degradation, inositol 1,4,5-trisphosphate
   (IP3) and diacylglycerol (DAG), mediate the mobilization of
   intracellular calcium and the activation of PKC, which act
   synergistically to evoke specific cellular responses.
   Signal transmission across the membrane is completed.
                     GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
   March 20, 2013    YS.2013                                         39
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               40
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               41
2. Role of PI in membrane protein anchoring

a. Specific proteins can be covalently attached via a carbohydrate
   bridge to membrane bound PI.

b.     Examples of such proteins include alkaline phosphatase (a digestive
      enzyme found on the surface of the small intestine that attacks
      organic phosphates), and acetylcholine esterase (an enzyme of the
      postsynaptic membrane that degrades the neurotransmitter
      acetylcholine).

c. Cell surface proteins bound to glycosyl phosphatidylinositol (GPI)
   are also found in a variety of parasitic protozoans (for example,
   Trypanosomes and Leishmania).


                        GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
     March 20, 2013     YS.2013                                       42
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               43
d. Being attached to a membrane lipid rather than being an
    integral part of the membrane) allows GPI-anchored proteins
    rapid lateral mobility on the surface of the plasma membrane.

 e. The protein can be cleaved from its anchor by the action of
    phospholipase C releasing diacylglycerol.

 f. A deficiency in the synthesis of GPI in hematopoietic cells
    results in a hemolytic disease, paroxysmal nocturnal
    hemoglobinuria.




                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                                          44
E. Phosphatidylglycerol (PG) and cardiolipin
          PG occurs in relatively large amounts in mitochondrial
           membranes and is a precursor of cardiolipin.

          It is synthesized by a two-step reaction from CDPdiacylglycerol
           and glycerol 3-phosphate.

     Cardiolipin (diphosphatidylglycerol, is composed of two
molecules of phosphatidic acid connected by a molecule of glycerol.

     It is synthesized by the transfer of diacylglycerophosphate from
      CDP-diacylglycerol to a preexisting molecule of
phosphatidylglycerol.

                        GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
    March 20, 2013      YS.2013                                        45
Sphingomyelin

         Sphingomyelin, a sphingosine-based
phospholipid, is a major structural lipid in the
membranes of nerve tissue.
         The synthesis of sphingomyelin is shown
          in Figure, Briefly, palmitoyl CoA
condenses with serine, as coenzyme A                   and
the carboxyl group (as CO2) of              serine are
lost.
         This reaction, like the decarboxylation
          reactions involving amino acids, requires
          pyridoxal phosphate (a derivative of
                        GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
vitamin B6) as a coenzyme.
   March 20, 2013       YS.2013                               46
      The product is reduced in an NADPH-requiring reaction to
    sphinganine, which is acylated at the amino group with one of a
       variety of long-chain fatty acids, and then desaturated to produce
       a ceramide--the immediate precursor of sphingomyelin.

       A ceramide with a fatty acid thirty carbons long is a major
        component of skin, and regulates skin's water permeability.

       Phosphorylcholine from phosphatidylcholine is transferred to the
        ceramide, producing sphingomyelin and diacylglycerol.

          Sphingomyelin of the myelin sheath contains predominantly
           longer-chain fatty acids such as lignoceric acid and nervonic
     acid.
           whereas gray matter of the brain has sphingomyelin that contains
           primarily stearic acid.
    March 20, 2013
                         GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
                         YS.2013                                         47
IV. DEGRADATION OF PHOSPHOLIPIDS

          The degradation of phosphoglycerides is performed by
           phospholipases found in all tissues and pancreatic juice.

          A number of toxins and venoms have phospholipase activity, and
           several pathogenic bacteria (Baccili) produce phospholipases that
           dissolve cell membranes and allow the spread of infection.

          Sphingomyelin is degraded by the lysosomal phospholipase,
           sphingomyelinase.



                         GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
    March 20, 2013       YS.2013                                        48
A. Degradation of phosphoglycerides

a. Phospholipases hydrolyze the phosphodiester bonds of phospho-
       glycerides, with each enzyme cleaving phospholipid at a
   specific site.
b. The major enzymes responsible for degrading phosphoglycerides
   are shown in on next slide.

c. Removal of the fatty acid from carbon 1 or 2 of a
   phosphoglyceride produces a lysophosphoglyceride, which is the
   substrate for lysophospholipases.

d.      Phospholipases release molecules that can serve as messengers
      (DAG and IP3), or that are the substrates for synthesis of
      messengers (arachidonic acid).
                             GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
     March 20, 2013          YS.2013                                    49
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               50
e. Phospholipases are responsible not only for degrading phospholipids,
   but also for remodeling them.

e.     For example, phospholipases A1 and A2 remove specific fatty acids
      from membrane-bound phospholipids; these can be replaced with
      alternative fatty acids using fatty acyl CoA transferase.

g. This mechanism is used as one way to create the unique
   lung surfactant, dipalmitoylphosphatidylcholine and to
   insure that carbon 2 of PI (and sometimes of PC) is bound to
   arachidonic acid.



                      GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
     March 20, 2013   YS.2013                                       51
B. Degradation of sphingomyelin
a. 1-Sphingomyelin is degraded by sphingomyelinase, a lysosomal
   enzyme that hydrolytically removes phosphorylcholine, leaving a
   ceramide.
   2-The ceramide is, in turn, cleaved by ceramidase into sphingosine
   and a free fatty acid.

b. The ceramide and sphingosine released by the degradation of
   sphingomyelin play a role as intracellular messengers.

c. Ceramides appear to be involved In the response to stress, and
   sphingosine inhibits protein kinase C.

d. Niemann-Pick disease (Types A and B) is an autosomal recessive
   disease caused by the inability to degrade sphingomyelin. The
   deficient enzyme is sphingomyelinase-A type of phospholipase C.
                      GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
  March 20, 2013      YS.2013                                       52
e.             In the severe infantile form (type A), the liver and spleen
are the primary sites of lipid deposits and are, therefore, tremendously
               enlarged. The lipid consists primarily of the
sphingomyelin that cannot be degraded (slide 42).

f.           Infants with this disease have rapid, progressive
neurodegenerative deposition of sphingomyelin in CNS,
      and they die in early childhood.

g.          A less severe variant (type B) causes little to no damage to neural
            tissue, but lungs, spleen, liver, and bone marrow are affected,
            resulting in a chronic form of the disease, with a life expectancy
            only to early adulthood.


                         GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
     March 20, 2013      YS.2013                                           53
h.    Although Niemann-Pick disease occurs in all ethnic groups.
      both type A and B occur with greater frequency in the
Ashkenazi Jewish ) population than in the general population.

i.          In the Ashkenazi Jewish population, the incidence of type A
is          1:40,000 live births, and that of type B is 1:80,000.

j.                 The incidence of Niemann-Pick disease in the general
            population is less than 1:100,000.




                       GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
 March 20, 2013        YS.2013                                        54
GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               55
Conclusions
 1.Introduction to lipids
 2.Structure of Glycerophospholipids and sphingolipids.
 3.Synthesis TG,phospholipids: Phosphatidic acid, PC,
 PE and PC, cardiolipin and sphingomyelin etc.
 4.Degradation of phospholipids by phosphalipases.
 5.Role of phosphatidyl choline in lung surfactant
 6.Role of PI in signal transduction and membrane
 anchoring .


                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                                  56
THANK YOU




                 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
March 20, 2013   YS.2013                               57

Contenu connexe

Tendances

lipid clinical importance sdk 2013
 lipid clinical importance sdk 2013 lipid clinical importance sdk 2013
lipid clinical importance sdk 2013Dr-HAMDAN
 
Lipid Chemistry by Dr Anurag Yadav
Lipid Chemistry by Dr Anurag YadavLipid Chemistry by Dr Anurag Yadav
Lipid Chemistry by Dr Anurag YadavDr Anurag Yadav
 
Lipisids presentation
Lipisids presentationLipisids presentation
Lipisids presentationNabeel Amjad
 
Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...
Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...
Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...Ripudaman Manjitsingh
 
Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...
Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...
Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...Ashok Katta
 
Phospholipid complex ppt
Phospholipid complex pptPhospholipid complex ppt
Phospholipid complex pptAtul Chaudhary
 
Lipids
LipidsLipids
LipidsMaria
 
Lipids, classification, digestion and absorption
Lipids, classification, digestion and absorptionLipids, classification, digestion and absorption
Lipids, classification, digestion and absorptionHu--da
 
Chemistry of Lipids
Chemistry of LipidsChemistry of Lipids
Chemistry of Lipidsenamifat
 
Fatty acids, omega 6 fatty acids, classification of fatty acids
Fatty acids, omega 6 fatty acids, classification of fatty acidsFatty acids, omega 6 fatty acids, classification of fatty acids
Fatty acids, omega 6 fatty acids, classification of fatty acidsmuti ullah
 
Compound lipids
Compound lipidsCompound lipids
Compound lipidsNoor Zada
 

Tendances (20)

lipid clinical importance sdk 2013
 lipid clinical importance sdk 2013 lipid clinical importance sdk 2013
lipid clinical importance sdk 2013
 
CL- 01: Fatty acid (Derived lipids)
CL- 01: Fatty acid (Derived lipids)CL- 01: Fatty acid (Derived lipids)
CL- 01: Fatty acid (Derived lipids)
 
Metabolism of acylglycerols and sphingolipids
Metabolism of acylglycerols and sphingolipidsMetabolism of acylglycerols and sphingolipids
Metabolism of acylglycerols and sphingolipids
 
Lipid Chemistry by Dr Anurag Yadav
Lipid Chemistry by Dr Anurag YadavLipid Chemistry by Dr Anurag Yadav
Lipid Chemistry by Dr Anurag Yadav
 
Chemistry of lipid
Chemistry of lipidChemistry of lipid
Chemistry of lipid
 
Lipisids presentation
Lipisids presentationLipisids presentation
Lipisids presentation
 
Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...
Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...
Lipids by Dr Ripudaman,Assistant Professor ,Anjuman Islam School of Pharmacy ...
 
Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...
Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...
Complex Lipids (Phosholipids, Glycolipids and Lipoproteins) (Chemistry of Lip...
 
Phospholipids
PhospholipidsPhospholipids
Phospholipids
 
Lipids
LipidsLipids
Lipids
 
Phospholipid complex ppt
Phospholipid complex pptPhospholipid complex ppt
Phospholipid complex ppt
 
Lipids
LipidsLipids
Lipids
 
Lipids, classification, digestion and absorption
Lipids, classification, digestion and absorptionLipids, classification, digestion and absorption
Lipids, classification, digestion and absorption
 
Chemistry of Lipids
Chemistry of LipidsChemistry of Lipids
Chemistry of Lipids
 
Fatty acids, omega 6 fatty acids, classification of fatty acids
Fatty acids, omega 6 fatty acids, classification of fatty acidsFatty acids, omega 6 fatty acids, classification of fatty acids
Fatty acids, omega 6 fatty acids, classification of fatty acids
 
Lipids
Lipids Lipids
Lipids
 
Chem 134 unit 8 lipids
Chem 134 unit 8 lipidsChem 134 unit 8 lipids
Chem 134 unit 8 lipids
 
lipids
 lipids lipids
lipids
 
Compound lipids
Compound lipidsCompound lipids
Compound lipids
 
Fatty acids profile
Fatty acids profileFatty acids profile
Fatty acids profile
 

Similaire à Msb 203...cardio res sys.tg.pl.sl

chemistry of lipids 2022 TG & compound lipids.ppt
chemistry of lipids 2022 TG & compound lipids.pptchemistry of lipids 2022 TG & compound lipids.ppt
chemistry of lipids 2022 TG & compound lipids.pptssuserc8fe0f
 
Metabolism of phospholipids
Metabolism of phospholipidsMetabolism of phospholipids
Metabolism of phospholipidsRamesh Gupta
 
BIOSYNTHESIS OF PHOSPHOLIPIDS-1.pptx
BIOSYNTHESIS  OF PHOSPHOLIPIDS-1.pptxBIOSYNTHESIS  OF PHOSPHOLIPIDS-1.pptx
BIOSYNTHESIS OF PHOSPHOLIPIDS-1.pptxASathiyaraji1
 
Biochem. lipids for midwife 6.pptx
Biochem. lipids for midwife 6.pptxBiochem. lipids for midwife 6.pptx
Biochem. lipids for midwife 6.pptxNatiphBasha
 
Eicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsEicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsdinesh kumar
 
Lipids and fatty acids.pptx
Lipids and fatty acids.pptxLipids and fatty acids.pptx
Lipids and fatty acids.pptxRASHMI M G
 
lipid chemistry 2023.pptx
lipid chemistry 2023.pptxlipid chemistry 2023.pptx
lipid chemistry 2023.pptxAyman Hany
 
Compound lipids and associated disorders
Compound lipids and associated disordersCompound lipids and associated disorders
Compound lipids and associated disordersAmanChauhan139
 
CHEMISTRY OF LIPIDS(Dr M PRIYANKA)
CHEMISTRY OF LIPIDS(Dr M PRIYANKA)CHEMISTRY OF LIPIDS(Dr M PRIYANKA)
CHEMISTRY OF LIPIDS(Dr M PRIYANKA)MINDS MAHE
 
Biosynthesis of phospholipids
Biosynthesis of phospholipidsBiosynthesis of phospholipids
Biosynthesis of phospholipidsNusrat Sheikh
 
2011 lipids 2
2011 lipids 22011 lipids 2
2011 lipids 2MUBOSScz
 
Biosynthesis of glycerides, phospholipids and cholesterol
Biosynthesis of glycerides, phospholipids and cholesterolBiosynthesis of glycerides, phospholipids and cholesterol
Biosynthesis of glycerides, phospholipids and cholesterolKrishitaMukherjee
 
Lipid metabolism for Dental college
Lipid metabolism for Dental collegeLipid metabolism for Dental college
Lipid metabolism for Dental collegeIAU Dent
 

Similaire à Msb 203...cardio res sys.tg.pl.sl (20)

chemistry of lipids 2022 TG & compound lipids.ppt
chemistry of lipids 2022 TG & compound lipids.pptchemistry of lipids 2022 TG & compound lipids.ppt
chemistry of lipids 2022 TG & compound lipids.ppt
 
Metabolism of phospholipids
Metabolism of phospholipidsMetabolism of phospholipids
Metabolism of phospholipids
 
BIOSYNTHESIS OF PHOSPHOLIPIDS-1.pptx
BIOSYNTHESIS  OF PHOSPHOLIPIDS-1.pptxBIOSYNTHESIS  OF PHOSPHOLIPIDS-1.pptx
BIOSYNTHESIS OF PHOSPHOLIPIDS-1.pptx
 
Biochem. lipids for midwife 6.pptx
Biochem. lipids for midwife 6.pptxBiochem. lipids for midwife 6.pptx
Biochem. lipids for midwife 6.pptx
 
7. lipids
7. lipids7. lipids
7. lipids
 
Eicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical studentsEicosanoids.pptx for first year medical students
Eicosanoids.pptx for first year medical students
 
Lipids and fatty acids.pptx
Lipids and fatty acids.pptxLipids and fatty acids.pptx
Lipids and fatty acids.pptx
 
Lipids
LipidsLipids
Lipids
 
Lipoprotein
LipoproteinLipoprotein
Lipoprotein
 
Sept 9 bt202
Sept 9 bt202Sept 9 bt202
Sept 9 bt202
 
lipid chemistry 2023.pptx
lipid chemistry 2023.pptxlipid chemistry 2023.pptx
lipid chemistry 2023.pptx
 
Compound lipids and associated disorders
Compound lipids and associated disordersCompound lipids and associated disorders
Compound lipids and associated disorders
 
CHEMISTRY OF LIPIDS(Dr M PRIYANKA)
CHEMISTRY OF LIPIDS(Dr M PRIYANKA)CHEMISTRY OF LIPIDS(Dr M PRIYANKA)
CHEMISTRY OF LIPIDS(Dr M PRIYANKA)
 
Biosynthesis of phospholipids
Biosynthesis of phospholipidsBiosynthesis of phospholipids
Biosynthesis of phospholipids
 
2011 lipids 2
2011 lipids 22011 lipids 2
2011 lipids 2
 
Biosynthesis of glycerides, phospholipids and cholesterol
Biosynthesis of glycerides, phospholipids and cholesterolBiosynthesis of glycerides, phospholipids and cholesterol
Biosynthesis of glycerides, phospholipids and cholesterol
 
Lipid metabolism for Dental college
Lipid metabolism for Dental collegeLipid metabolism for Dental college
Lipid metabolism for Dental college
 
Lipid bio chemistry
Lipid bio chemistryLipid bio chemistry
Lipid bio chemistry
 
Phospholipids
PhospholipidsPhospholipids
Phospholipids
 
Chapter 8 lipids
Chapter 8 lipidsChapter 8 lipids
Chapter 8 lipids
 

Plus de Dr. Geoffrey K. K. Maiyoh

Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Dr. Geoffrey K. K. Maiyoh
 
Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Dr. Geoffrey K. K. Maiyoh
 
Chemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionChemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionDr. Geoffrey K. K. Maiyoh
 

Plus de Dr. Geoffrey K. K. Maiyoh (20)

Cancer in kenya
Cancer in kenyaCancer in kenya
Cancer in kenya
 
Celebrating Kenya
Celebrating KenyaCelebrating Kenya
Celebrating Kenya
 
Lecture 05.2014
Lecture 05.2014Lecture 05.2014
Lecture 05.2014
 
Lecture 04.2014
Lecture 04.2014Lecture 04.2014
Lecture 04.2014
 
Lecture 03.2014
Lecture 03.2014Lecture 03.2014
Lecture 03.2014
 
Classes of antimicrobial agents
Classes of antimicrobial agentsClasses of antimicrobial agents
Classes of antimicrobial agents
 
Lecture 01.2014
Lecture 01.2014Lecture 01.2014
Lecture 01.2014
 
Mineralocorticoids & glucocorticoids
Mineralocorticoids & glucocorticoidsMineralocorticoids & glucocorticoids
Mineralocorticoids & glucocorticoids
 
Molecular diagnostics
Molecular diagnosticsMolecular diagnostics
Molecular diagnostics
 
obesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndromeobesity diabetes and metabolic syndrome
obesity diabetes and metabolic syndrome
 
Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014Dsb 106. intergration of metabolism.2014
Dsb 106. intergration of metabolism.2014
 
Bpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolismBpt 114. purine and pyrimidine metabolism
Bpt 114. purine and pyrimidine metabolism
 
Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014Msp 304. gsd,gout,a cuduria and lesh.2014
Msp 304. gsd,gout,a cuduria and lesh.2014
 
Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014Msb 206. amino acid catab and fates of cs.2014
Msb 206. amino acid catab and fates of cs.2014
 
Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)Cellular respiration (glycolysis, TCA and ETC)
Cellular respiration (glycolysis, TCA and ETC)
 
Chemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introductionChemistry of Carbohydrates and Nucleic acids - An introduction
Chemistry of Carbohydrates and Nucleic acids - An introduction
 
ANTIBIOTICS Lecture 06
ANTIBIOTICS Lecture 06ANTIBIOTICS Lecture 06
ANTIBIOTICS Lecture 06
 
ANTIBIOTICS Lecture 05
ANTIBIOTICS Lecture 05ANTIBIOTICS Lecture 05
ANTIBIOTICS Lecture 05
 
Antibiotics Lecture 04
Antibiotics Lecture 04Antibiotics Lecture 04
Antibiotics Lecture 04
 
Antibiotics Lecture 03
Antibiotics Lecture 03Antibiotics Lecture 03
Antibiotics Lecture 03
 

Msb 203...cardio res sys.tg.pl.sl

  • 1. MSB 203: CARDIORESPIRATORY SYSTEM Dr. G.K. Maiyoh Department of Medical Biochemistry GKM/MUSOM.MEDBIOC.MSB203.CARDIORESSYS.2013 March 20, 2013 1
  • 2. Lecture Objective 1. To study the structure of physiologically important phospholipid classes- glycerophospholipids and sphingolipids. 2. To discuss the synthesis of phospholipids of clinical and physiological relevance and their degradation by phospholipases. 3. To study the role of phospholipids like phosphatidylinositol in signal transduction and membrane anchoring choline, ethanolamine and serine, cardiolipin and sphingomyelin . GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 2
  • 3. Lecture Outline 1. Introduction to Lipid 2. Overview of phospholipids. 3. Structure of Glycerophospholipids and sphingolipids. 4. Synthesis of phospholipids: Phosphatidic acid, phosphatidyl-choline, ethanolamine and serine, cardiolipin and sphingomyelin etc. 5. Degradation of phospholipids by phosphalipases. 6. Role of phosphatidyl choline in lung surfactant 7. Role of phsophatidylinositol in signal transduction and membrane anchoring . GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 3
  • 4. Lipids defined •A diverse group of compounds found in all living cells, insoluble in water but soluble in organic solvents such as ether, acetone and chloroform
  • 5. Lipids classification - Fatty acids (saturated/unsaturated) - Glycerol -Triglycerides -Phospholipids (glycero/sphingo) -Sterols (cholesterol and cholesterol esters) GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 5
  • 6. Cholesterol GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 6
  • 7. Fatty Acids The Length of the Carbon Chain long-chain, medium-chain, short-chain The Degree of Unsaturation saturated, unsaturated, monounsaturated, polyunsaturated The Location of Double Bonds omega-3 fatty acid, omega-6 fatty acid GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 7
  • 8. The Length of the Carbon Chain Short-chain Fatty Acid (less than 6 carbons) Medium-chain Fatty Acid (6-10 carbons) Long-chain Fatty Acid (12 or more carbons) GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 8
  • 9. Phosphatidic acid Biosynthesis TG and phospholipids share the same initial synthesis pathway TG and phospholipids both contain fatty acids linked by ester bonds to a glycerol , and are described as glycerolipids . The synthesis pathway starts by reducing dihydroxyacetone phosphateto glycerol phosphate, with NADH as the reductant. NAD+ dependent glycerol phosphate dehydrogenase dihydroxyacetone phosphate + NADH + H+ L-glycerol-3- phosphate + NAD+
  • 10. (Alternatively, existing glycerol molecules may be phosphorylated by glycerol kinase. glycerol kinase glycerol + ATP L-glycerol-3- phosphate + ADP
  • 11. Formation of active CoA thioester This is followed by two successive additions of acyl esters. Fatty acid (typically 16-18 C atoms) is first converted to the active CoA thioester by acyl CoA synthetase: acyl CoA synthetase  stearate (18:0) + HSCoA + ATP stearoyl-CoA + 5'-AMP + PPi
  • 12. Acylglycerols Acyl-CoA is then used to donate acyl ester groups to the glycerol backbone: acyltransferase L-glycerol-3-phosphate + acyl-CoA 1-acylglycerol-3- phosphate + HSCoA acyltransferase 1-acylglycerol-3-phosphate + stearoyl-CoA 1,2-diacylglycerol-3-phosphate + HSCoA Phosphatidic acid
  • 13. 1. glycerol phosphate dehydrogenase 2. glycerol kinase 3. acyl transferase
  • 14. Phosphatidic acid The last product, 1,2-diacylglycerol-3-phosphate, is also known as phosphatidic acid Its phospholipid derivatives are phosphatidyl-X. Phospholipids also tend to have a saturated fatty acid in position 1 and an unsaturated fatty acid in position 2. The fat synthesis (TG) pathway branches here from glycerophospholipid synthesis
  • 15. TG formation Phosphate is first removed by phosphatidic acid phosphatase, The acyltransferase can then add the third acyl ester group tomake triacylglycerol (or fat)
  • 16. Phospholipid  Polar compounds composed of alcohol attached by a phosphodiester bridge to either diacylglycerol or sphingosine.  Amphipathic in nature, has a hydrophilic head (phosphate + alcohol e.g., serine, ethanolamine, and choline) and a long, hydrophobic tail (fatty acids or derivatives ).  In membranes, the hydrophobic portion is associated with the nonpolar portions such as glycolipids, proteins, and cholesterol.  The hydrohilic polar head extends outward, facing intracellular or extracellular aqueous environment . See figure on next slide GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 16
  • 18. Glycero- phospholipids Phosphatidic acid 4 major glycerophospholipids are polar/charged:
  • 19. Membrane phospholipids also function as :  a reservoir for intracellular messengers, and,  for some proteins, phospholipids serve as anchors to cell membranes.  Non-membrane-bound phospholipids serve additional functions in the body, for example, •1 as components of lung surfactant and •2 essential components of bile, where their detergent properties aid "in the solubilization of cholesterol. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 19
  • 20. Glycerophospholipids : are formed from phosphatidic acid (PA) and an alcohol. Serine + PA -- phosphatidylserine (PS) Ethanolamine + PA -- phosphatidylethanolamine (cephalin) Choline + PA -- phosphatidylcholine (lecithin) PC Inositol + PA -- phosphatidylinositol (PI) Glycerol + PA -- phosphatidylglycerol (PG) GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 20
  • 21. (Cardiolipin) Two molecules of phosphatidic acid esterified through phosphate to an additional molecule of glycerol are called cardiolipin. (see next slide) This is the only human glycerophospholipid that is antigenic. cardiolipin is recognized by antibodies raised against Treponema the bacterium that causes syphylis [Cardiolipin is an important component of the inner mitochondrial membrane and bacterial membranes.] GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 21
  • 22. • Diphosphatidyl glycerol (cardiolipin) O O RCO-CH2 CH2-OCR O O RCO-CH CH-OCR O OH O CH2-O-P-O-CH2-CH-CH2-O-P-O-CH2 O- O- glycerol
  • 23. Plasmalogens When the fatty acid at carbon 1 of a glycerolphospholipid is replaced by an unsaturated alkyl group attached by an ether (rather than by an ester) linkage to the core glycerol : molecule, a plasmalogen is produced. Phosphatidalethanolamine is abundant in nerve tissue is a plasmalogen. Phosphatidalcholine (abundant in heart muscle) is the other quantitatively significant ether lipid in mammals. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 23
  • 24. March 20, 2013 24 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS
  • 25. Sphingophospholipids (or sphingomyelin) The backbone of sphingomyelin is the amino alcohol sphingosine, rather than glycerol. A long-chain fatty acid is attached to the amino group of sphingosine through an amide linkage, producing a ceramide, which serve as a precursor of glycolipids. The alcohol group at carbon 1 of sphingosine is esterified to phosphorylcholine, producing sphingomyelin, the only significant sphingophospholipid in humans. Sphingomyelin is an important component of the myelin of nerve fibers (myelin sheath) that insulates and protects neuronal fibers of the central nervous system. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 25
  • 27. Synthesis of Phospholipid 1. Glycerophospholipid (GP) synthesis involves either a. The donation of phosphatidic acid from CDP-diacylglycerol to an alcohol, or b. The donation of phosphomonoester of the alcohol from CDP- alcohol to 1,2-diacylglycerol. CDP is cytidine diphosphate. 2. In both cases, the CDP-bound structure is considered an "activated intermediate," and CMP is released as a side product of GP synthesis. 3. A key concept in phosphoglyceride synthesis, is activation either of diacylglycerol or the alcohol to be added by linkage with CDP. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 27
  • 28. 1 CMP 2 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 28
  • 29. 4. The fatty acids esterifies to the glycerol alcohol groups can vary widely, contributing to the heterogeneity of this group of compounds. 5. Phospholipids are synthesized in the Smooth ER-- then transported to Golgi apparatus and then membranes organelles or plasma membrane, or are secreted by exocytosis 6. There are two classes of phospholipids: Those have either glycerol as a backbone or contain sphingosine. 7. Both classes are found in membranes and play a role in the generation of lipid-signaling molecules. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 29
  • 30. Synthesis of phosphatidylethanolamine (PE) & phosphatidylcholine (PC) • PC & PE are most abundant phospholipids in eukaryotic cells. • The primary route of synthesis uses choline and ethanolamine obtained either from the diet or turnover of the body's phospholipids. • In the liver, PC also can be synthesized from phosphatidylserine (PS) and PE. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 30
  • 31. 1. Synthesis of PE and PC from preexisting choline and ethanolamine These synthetic pathways involve the phosphorylation of choline or ethanolamine by kinases, followed by conversion to the activated form, CDP-choline or CDP-ethanolamine Finally, choline-phosphate or ethanolamine-phosphate is transferred from the nucleotide (leaving CMP) to a molecule of diacylglycerol. Significance of choline reutilization The reutilization of choline is important because, whereas humans can synthesize choline de novo, the amount made is insufficient for our needs. Thus, choline is an essential dietary nutrient with an adequate intake of 550 mg for men and 420 mg for women. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 31
  • 32. Role of PC in lung surfactant 1. The major lipid component of lung surfactant--the extracellular fluid layer lining the alveoli is dipalmitoyl-phosphatidylcholine (DPPC, or dipalmitoylecithin). In DPPC, positions 1 and 2 on the glycerol are occupied by palmitate. 2. DPPC, made and secreted by granular pneumocytes 3. Surfactant serves to decrease the surface tension of this fluid layer, reducing the pressure needed to reinflate alveoli, thereby preventing alveolar collapse (atelectasis). 3. Respiratory distress syndrome (RDS) in pre-term infants is associated with insufficient surfactant production, and is a significant cause of neonatal deaths . 5. Lung maturity of the fetus can be gauged by determining the ratio of DPPC to sphingomyelin, usually written as the L (for lecithin)/S ratio, in amniotic fluid. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 32
  • 33. 6. A ratio of 2 or above is evidence of maturity, because it reflects the major shift from sphingomyelin to DPPC synthesis that occurs in the pneumocytes at about 32 weeks of gestation. 7. 1- Lung maturation can be accelerated by giving the mother glucocorticoids shortly before delivery. 2- Administration of natural or synthetic surfactant (by intratracheal instillation is also used in the prevention and treatment of infant RDS. 8. Respiratory distress syndrome due to an insufficient amount of surfactant can also occur in adults whose surfactant producing pneumocytes have been damaged or destroyed, for example, as an adverse side effect of immuno-suppressive medication or chemotherapeutic drug use. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 33
  • 34. 2: Synthesis of PC from phosphatidylserine (PS) in liver 1. The liver requires a mechanism for producing PC, even when free choline levels are low, because it exports significant amounts of PC in the bile and as a component of serum lipoproteins. 2. To provide the needed PC, PS is decarboxylated to phosphatidylethanolamine (PE) by PS decarboxylase, an enzyme requiring pyridoxal phosphate as a cofactor. 3. PE then undergoes 3 methylation steps to produce PC, as illustrated in the next slide. 4. S-adenosylmethionine (SAM) is the methyl group donor lead to S-adenosylhomocysteine GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 34
  • 36. C. Phosphatidylserine (PS) The primary pathway for synthesis of PS in mammalian tissues is provided by the base exchange reaction, in which the ethanolamine of PE is exchanged for free serine This reaction, although reversible, is used primarily to produce the PS required for membrane synthesis. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 36
  • 37. D. Phosphatidylinositol (PI) PI is synthesized from free inositol and CDP-diacylglycerol PI is an unusual phospholipid in that it often contains stearic acid on carbon 1 and arachidonic acid on carbon 2 of the glycerol. PI, therefore, serves as a reservoir of arachidonic acid in membranes and, thus, provides the substrate for prostaglandin synthesis when required. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 37
  • 39. 1. Role of PI in signal transmission across membranes: a. The phosphorylation of membrane-bound phosphatidylinositol produces polyphosphoinositides, for example, phosphatidylinositol 4,5- bisphosphate (PIP2). (See next slide) b. The degradation of PIP2 by phospholipase C occurs in response to the binding of neurotransmitters, hormones, and growth factors to receptors on the cell membrane. c. The products of this degradation, inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DAG), mediate the mobilization of intracellular calcium and the activation of PKC, which act synergistically to evoke specific cellular responses. Signal transmission across the membrane is completed. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 39
  • 42. 2. Role of PI in membrane protein anchoring a. Specific proteins can be covalently attached via a carbohydrate bridge to membrane bound PI. b. Examples of such proteins include alkaline phosphatase (a digestive enzyme found on the surface of the small intestine that attacks organic phosphates), and acetylcholine esterase (an enzyme of the postsynaptic membrane that degrades the neurotransmitter acetylcholine). c. Cell surface proteins bound to glycosyl phosphatidylinositol (GPI) are also found in a variety of parasitic protozoans (for example, Trypanosomes and Leishmania). GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 42
  • 44. d. Being attached to a membrane lipid rather than being an integral part of the membrane) allows GPI-anchored proteins rapid lateral mobility on the surface of the plasma membrane. e. The protein can be cleaved from its anchor by the action of phospholipase C releasing diacylglycerol. f. A deficiency in the synthesis of GPI in hematopoietic cells results in a hemolytic disease, paroxysmal nocturnal hemoglobinuria. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 44
  • 45. E. Phosphatidylglycerol (PG) and cardiolipin  PG occurs in relatively large amounts in mitochondrial membranes and is a precursor of cardiolipin.  It is synthesized by a two-step reaction from CDPdiacylglycerol and glycerol 3-phosphate.  Cardiolipin (diphosphatidylglycerol, is composed of two molecules of phosphatidic acid connected by a molecule of glycerol.  It is synthesized by the transfer of diacylglycerophosphate from CDP-diacylglycerol to a preexisting molecule of phosphatidylglycerol. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 45
  • 46. Sphingomyelin  Sphingomyelin, a sphingosine-based phospholipid, is a major structural lipid in the membranes of nerve tissue.  The synthesis of sphingomyelin is shown in Figure, Briefly, palmitoyl CoA condenses with serine, as coenzyme A and the carboxyl group (as CO2) of serine are lost.  This reaction, like the decarboxylation reactions involving amino acids, requires pyridoxal phosphate (a derivative of GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS vitamin B6) as a coenzyme. March 20, 2013 YS.2013 46
  • 47. The product is reduced in an NADPH-requiring reaction to sphinganine, which is acylated at the amino group with one of a variety of long-chain fatty acids, and then desaturated to produce a ceramide--the immediate precursor of sphingomyelin.  A ceramide with a fatty acid thirty carbons long is a major component of skin, and regulates skin's water permeability.  Phosphorylcholine from phosphatidylcholine is transferred to the ceramide, producing sphingomyelin and diacylglycerol.  Sphingomyelin of the myelin sheath contains predominantly longer-chain fatty acids such as lignoceric acid and nervonic acid. whereas gray matter of the brain has sphingomyelin that contains primarily stearic acid. March 20, 2013 GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS YS.2013 47
  • 48. IV. DEGRADATION OF PHOSPHOLIPIDS  The degradation of phosphoglycerides is performed by phospholipases found in all tissues and pancreatic juice.  A number of toxins and venoms have phospholipase activity, and several pathogenic bacteria (Baccili) produce phospholipases that dissolve cell membranes and allow the spread of infection.  Sphingomyelin is degraded by the lysosomal phospholipase, sphingomyelinase. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 48
  • 49. A. Degradation of phosphoglycerides a. Phospholipases hydrolyze the phosphodiester bonds of phospho- glycerides, with each enzyme cleaving phospholipid at a specific site. b. The major enzymes responsible for degrading phosphoglycerides are shown in on next slide. c. Removal of the fatty acid from carbon 1 or 2 of a phosphoglyceride produces a lysophosphoglyceride, which is the substrate for lysophospholipases. d. Phospholipases release molecules that can serve as messengers (DAG and IP3), or that are the substrates for synthesis of messengers (arachidonic acid). GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 49
  • 51. e. Phospholipases are responsible not only for degrading phospholipids, but also for remodeling them. e. For example, phospholipases A1 and A2 remove specific fatty acids from membrane-bound phospholipids; these can be replaced with alternative fatty acids using fatty acyl CoA transferase. g. This mechanism is used as one way to create the unique lung surfactant, dipalmitoylphosphatidylcholine and to insure that carbon 2 of PI (and sometimes of PC) is bound to arachidonic acid. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 51
  • 52. B. Degradation of sphingomyelin a. 1-Sphingomyelin is degraded by sphingomyelinase, a lysosomal enzyme that hydrolytically removes phosphorylcholine, leaving a ceramide. 2-The ceramide is, in turn, cleaved by ceramidase into sphingosine and a free fatty acid. b. The ceramide and sphingosine released by the degradation of sphingomyelin play a role as intracellular messengers. c. Ceramides appear to be involved In the response to stress, and sphingosine inhibits protein kinase C. d. Niemann-Pick disease (Types A and B) is an autosomal recessive disease caused by the inability to degrade sphingomyelin. The deficient enzyme is sphingomyelinase-A type of phospholipase C. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 52
  • 53. e. In the severe infantile form (type A), the liver and spleen are the primary sites of lipid deposits and are, therefore, tremendously enlarged. The lipid consists primarily of the sphingomyelin that cannot be degraded (slide 42). f. Infants with this disease have rapid, progressive neurodegenerative deposition of sphingomyelin in CNS, and they die in early childhood. g. A less severe variant (type B) causes little to no damage to neural tissue, but lungs, spleen, liver, and bone marrow are affected, resulting in a chronic form of the disease, with a life expectancy only to early adulthood. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 53
  • 54. h. Although Niemann-Pick disease occurs in all ethnic groups. both type A and B occur with greater frequency in the Ashkenazi Jewish ) population than in the general population. i. In the Ashkenazi Jewish population, the incidence of type A is 1:40,000 live births, and that of type B is 1:80,000. j. The incidence of Niemann-Pick disease in the general population is less than 1:100,000. GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 54
  • 56. Conclusions 1.Introduction to lipids 2.Structure of Glycerophospholipids and sphingolipids. 3.Synthesis TG,phospholipids: Phosphatidic acid, PC, PE and PC, cardiolipin and sphingomyelin etc. 4.Degradation of phospholipids by phosphalipases. 5.Role of phosphatidyl choline in lung surfactant 6.Role of PI in signal transduction and membrane anchoring . GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 56
  • 57. THANK YOU GKM/MUSOM.MEDBIOC.MSB203.CARDIORESS March 20, 2013 YS.2013 57